Ventana PD-L1 SP263

The University of Virginia awarded a contract to Roche Diagnostic Corporation on June 6, 2026, for the procurement of diagnostic reagents and consumables. The primary deliverable is one unit of VENTANA PD-L1 SP263, a programmed death-ligand 1 immunohistochemistry assay kit used in pathology and oncology laboratories for diagnostic testing. The contract cumulative value is $2,986.82, with a unit price of $2,986.82 per item. The delivery recipient is identified as Barushi Gopitha Amarasinghe.

As the contracting organization, the University of Virginia serves as the procuring entity in the Commonwealth of Virginia. While the specific period of performance is not detailed in the contract documentation, the award date of June 6, 2026, establishes the contract initiation point. The modest contract value and single-unit purchase indicate this represents a routine procurement of specialized laboratory reagents for diagnostic testing purposes, likely supporting the university's pathology or research operations.